Dr. ZEINAB ABOTALIB MRCOG, DGO, Consultant Obs/Gyna Infertility & IVF Assisted Conception Dr. ZEINAB ABOTALIB MRCOG, DGO, Associate Professor & Consultant Obs/Gyna Infertility & IVF
Assisted Conception IUI: intrauterine insemination IVF: in vitro fertilization ICSI: intracytoplasmic sperm injection GIFT: gamete intrafallopian transfer ZIFT: zygote intrafallopian transfer PESA: percutaneous epididymal sperm aspiration
Assisted Conception ET: embryo transfer TESE: testicular sperm extraction SUZI: subzonal sperm injection PGD: preimplantation genetic diagnosis
Assisted Conception Objective To bring sperm and oocyte close to each other to promote chances of fertilization and, ultimately, achieve a pregnancy
Assisted Conception Main types: IUI: intrauterine insemination IVF: in vitro fertilization ICSI: intracytoplasmic sperm injection
Assisted Conception Required procedures Superovulation Sperm preparation Assisted fertilization
Superovulation Hormonal manipulation to enhance ovulation and release multiple oocytes during ovulatory cycle
Superovulation Drugs used: Human menopausal gonadotropin Taken from urine of postmenopausal women Follicle stimulating hormone (FSH) and luteinizing hormone (LH) activity Recombinant FSH Recombinant LH
Superovulation- protocol Gonadotropin for 9-11 days Monitoring follicular development by transvaginal ultrasound Follicles 16 -18 mm in diameter 10,000 IU hCG Oocytes maturation Ovulation
Sperm Preparation Select PMNS Remove seminal plasma, WBC, and bacteria Sperm capacitation Coating of sperm with seminal plasma proteins Allow sperm to become fertile In vivo or in test tube
Intrauterine insemination Sperm sample deposited in uterus just before release of an oocyte (s) in a natural or stimulated cycle Soft catheter Give hCG at injection or up to 24 hrs later Sperm volume: 0.2-0.3 ml Pregnancy rates Around 15% per cycle
Gamete intrafallopian transfer Laparoscopic technique in which oocyte and sperm placed in fallopian tube, allowing in vivo fertilization Procedure Superovulation US guided transvaginal oocyte retrieval 0.1-0.2 mil sperm with 2-3 oocytes
In vitro fertilization - IVF Taking oocytes from woman Fertilizing them in lab with her partner's sperm Transferring resulting embryos back to her uterus 3 or 5 days later
IVF Procedure Superovulation Insemination Embryo transfer Luteal support
IVF - Superovulation Gonadotropin stimulation Monitoring follicular development US guided transvaginal oocyte retrieval Oocyte fertilization with sperm
IVF - Insemination Containers used Test tubes, Petri dishes, multi-well dishes Each oocyte inseminated with 0.5-1.0 mil PMNS Fertilization detected 12-20 hrs later by presence of 2 pronuclei in oocyte cytoplasm 2 polar bodies in perivitelline space
IVF - Insemination Syngamy (combination of maternal and paternal pronuclei 24 hrs after insemination Further cleavages occur at 24 hr intervals
IVF - Embryo transfer Embryos transferred to uterus on 2nd or 3rd day after in vitro insemination 4-8 cells embryos 2-3 embryos transferred in 20 µl of culture fluid Transabdominal US to see fluid placed in uterus Cryopreserve excess embryos
IVF - Luteal support Progesterone (P4) necessary for pregnancy maintenance Premature luteolysis in some superovulatory regimens P4 supplementation until menses occur or woman has positive pregnancy test
Intracytoplasmic sperm injection - ICSI Injection of single sperm into single oocyte in order to get fertilization Procedure Superovulation US guided transvaginal oocyte retrieval IVF Oocytes injected with sperm using special microscopes, needles and micromanipulation equipment
ICSI - Indications Low sperm concentration, motility, abnormal morphology Antisperm antibodies Fertilization failure after conventional IVF Ejaculatory disorders absence of vas deferens or obstruction of ejaculatory ducts
Assisted Hatching Indications Couples having IVF with Female partner's age over 37 Poor quality embryos Excessive fragmentation Slow rates of cell division
Assisted Hatching – Procedure Embryo held with a specialized holding pipette A needle used to expel an acidic solution against ZP A small hole made in ZP Embryo washed and put back in culture in incubator ET shortly after hatching procedure Hope for the best
Further Advances And Uses Of Assisted Conception Technology Cryopreservation of Sperm Embryo Oocyte Ovarian tissue Growth of human follicles and oocytes in vitro In vitro maturation and transplantation of human spermatozoa
Assisted Reproductive Technology (ART) Dr. Abdelsalam Talafha American Board Certified, Comparative Veterinary Obstetrics and Gynecology
ART Infertility Inability to conceive after 1 year of unprotected and regular sexual intercourse Primary infertility Couples have never had children Secondary infertility Couples initiated conception in the past and then had difficulty
ART Infertility Female partner: 35% Male partner: 35% Both partners: 20% Unknown cause: 10% Infertility more common with increasing age
ART USA women infertility rate Ages 20-24: 4.1% Ages 25-29: 5.5% 80% of infertility cases can be diagnosed 85% of cases can be successfully treated
ART Female infertility Disorders of ovulation: 27% Fallopian tube disorders: 22% Pelvic adhesions: 12% Endometriosis: 5% to 15% Hyperprolactinemia: 7%
ART Male infertility Abnormal semen parameters Count, motility, morphology Infertility treatment Correcting underlying abnormality ART
ART Main techniques IUI IVF - embryo transfer ICSI Assisted hatching
Preimplantation Genetic Diagnosis (PGD) Identify genetic conditions in embryo before ET Hemophilia Cystic fibrosis Aneuploidy
PGD Hemophilia Hereditary bleeding disorder Absence of a blood protein essential for clotting Types A: lack of factor VIII Type B: lack of factor IX
PGD Cystic fibrosis Genetic disease Defective gene causes body to produce abnormally thick, sticky mucus that obstruct Lungs Pancreas
PGD Aneuploidy Having less than or more than normal diploid number of chromosomes Monosomy Trisomy Triploidy
PGD Performed with IVF 8-cell stage (3 days old) embryo biopsy Obtain 1-2 blastomeres for genetic
Three day old embryos
PGD Genetic analysis Multicolor fluorescence in situ hybridization (FISH) Polymerase chain reaction (PCR)
FISH Detects Number of chromosomes Sexing embryos Sex chromosome aneuploidy Whole-chromosome paints for detection of rearrangements and identification of marker chromosomes Analyze polar bodies
FISH Fuorescent probes that bind to specific chromosomes are labeled with biotin for detection by specific fluorochrome-conjugated antibodies under a fluorescent microscope
Interphase nucleus X Y
Triploid Normal Diploid Tetraploid Missing chromosomes
PGD Double trisomy Monosomy